These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32876438)

  • 21. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
    Rajkumar S; Prabaharan M
    Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway.
    Zhang N; Liu X; Li L; Legerski R
    DNA Repair (Amst); 2007 Nov; 6(11):1670-8. PubMed ID: 17669695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
    Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
    Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
    Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
    Shen Z; Li Y; Kohama K; Oneill B; Bi J
    Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide.
    Mizutani H; Tada-Oikawa S; Hiraku Y; Kojima M; Kawanishi S
    Life Sci; 2005 Feb; 76(13):1439-53. PubMed ID: 15680309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
    Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
    J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, in vitro stability, and antiproliferative effect of d-cysteine modified GnRH-doxorubicin conjugates.
    Li S; Zhao H; Chang X; Wang J; Zhao E; Yin Z; Mao X; Deng S; Hao T; Wang H; Yang Y
    J Pept Sci; 2019 Jan; 25(1):e3135. PubMed ID: 30467919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 interacts directly with the Fanconi anemia protein FANCA.
    Folias A; Matkovic M; Bruun D; Reid S; Hejna J; Grompe M; D'Andrea A; Moses R
    Hum Mol Genet; 2002 Oct; 11(21):2591-7. PubMed ID: 12354784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis.
    Joseph MM; Aravind SR; George SK; Raveendran Pillai K; Mini S; Sreelekha TT
    Eur J Pharm Biopharm; 2015 Jun; 93():183-95. PubMed ID: 25864443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study.
    Aroui S; Brahim S; Waard MD; Kenani A
    Biochem Biophys Res Commun; 2010 Jan; 391(1):419-25. PubMed ID: 19914216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
    Wang H; Yin H; Yan F; Sun M; Du L; Peng W; Li Q; Feng Y; Zhou Y
    Oncotarget; 2015 Feb; 6(5):2827-42. PubMed ID: 25605018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DOX-loaded peptide dendritic copolymer nanoparticles for combating multidrug resistance by regulating the lysosomal pathway of apoptosis in breast cancer cells.
    Wang J; Li N; Cao L; Gao C; Zhang Y; Shuai Q; Xie J; Luo K; Yang J; Gu Z
    J Mater Chem B; 2020 Feb; 8(6):1157-1170. PubMed ID: 31951231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity.
    Swift LP; Cutts SM; Nudelman A; Levovich I; Rephaeli A; Phillips DR
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):739-49. PubMed ID: 17594094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput screening identifies novel agents eliciting hypersensitivity in Fanconi pathway-deficient cancer cells.
    Gallmeier E; Hucl T; Brody JR; Dezentje DA; Tahir K; Kasparkova J; Brabec V; Bachman KE; Kern SE
    Cancer Res; 2007 Mar; 67(5):2169-77. PubMed ID: 17332347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted anticancer drug delivery through anthracycline antibiotic bearing functionalized quantum dots.
    Bajwa N; Kumar Mehra N; Jain K; Kumar Jain N
    Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1774-82. PubMed ID: 26508412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
    Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
    J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery.
    Alexander CM; Hamner KL; Maye MM; Dabrowiak JC
    Bioconjug Chem; 2014 Jul; 25(7):1261-71. PubMed ID: 24911830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.